SQZ Biotechnologies Co·4

Feb 25, 5:53 PM ET

BERNSTEIN HOWARD PHD MD 4

4 · SQZ Biotechnologies Co · Filed Feb 25, 2021

Insider Transaction Report

Form 4
Period: 2021-02-23
BERNSTEIN HOWARD PHD MD
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2021-02-23+72,90072,900 total
    Exercise: $16.85Exp: 2031-02-22Common Stock (72,900 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying securities on February 23, 2022 and in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION